Acne fulminans vs acne conglobata: how to tell severe acne subtypes apart

Almost every editor lumps severe acne into one bucket and calls it cystic. That is not how it works in the dermatology clinic. Two of the worst subtypes, fulminans and conglobata, look alike from across the room but want very different first moves. Telling them apart matters because the wrong starting drug can wreck the skin worse.

Acne fulminans: what it does well to be recognised

Fulminans is the one that scares the dermatologist. It comes on fast. Within a few weeks a previously moderate-acne face turns into deep ulcerative nodules that bleed and crust over. The lesions sit mostly on the chest, back, and shoulders. Systemic signs come with it: fever, joint pain, weight loss, an elevated white-cell count. A teenage boy on isotretinoin who suddenly worsens is the classic trigger picture.

The mechanism is roughly an autoinflammatory overshoot, not a bacterial overgrowth. That is why simple antibiotics rarely move it. The standard first-line response is oral prednisone for four to six weeks to settle the inflammation, then isotretinoin started at a low dose with the steroid still tapering. Get that order wrong and the skin can ulcerate further. I have read enough JAAD case reports to know this is the type of acne where general practitioners should refer out within forty-eight hours.

Acne conglobata: what it does well to be recognised

Conglobata is the slow, ugly one. It builds over years rather than weeks. Interconnected nodules and cysts form sinus tracts under the skin, which fill, drain, and refill. The lesions favour the trunk and buttocks as much as the face, and double-headed comedones (two black openings linked by a single channel underneath) are a near-pathognomonic sign.

It runs in families. It correlates with the broader follicular occlusion tetrad, alongside cystic acne at its more severe end, hidradenitis suppurativa, and dissecting cellulitis. Most patients have had it since their late teens and still have it in their thirties. The first-line treatment is isotretinoin straight away at a meaningful dose, often combined with intralesional corticosteroid injections into the worst nodules. Skin care after a flare is mostly damage limitation and scar management.

How to choose what you do at home

You do not. That is the honest answer. If your acne is ulcerating, bleeding, or accompanied by joint pain or fever, the question is not which skincare line to buy. The question is when you can see a dermatologist. Same week, ideally.

For supporting care while you wait or while treatment is underway, the rules are narrow. A gentle non-foaming cleanser. A bland ceramide moisturizer. Mineral SPF in the morning. Nothing with retinol, nothing with strong acids, no benzoyl peroxide on broken skin. Barrier repair work sits adjacent to all of this. Five short words: support the skin, not treat.

If you have been told you have nodulocystic acne and you are not sure which subtype, here is the rough decision: rapid onset with systemic symptoms, that is fulminans territory, get an emergency referral. Years of slow-build interconnected lesions plus family history, that is conglobata, get a referral but the urgency is different.

The contrarian section: cystic is not a useful word

The skincare internet uses cystic acne to mean anything painful and deep. It is a lazy term that hides three or four different conditions with different prognoses. A single hormonal cyst on the jawline before a period is not the same disease as conglobata with sinus tracts in the armpits. Lumping them together is how people end up trying a salicylic acid serum on a condition that needs oral isotretinoin.

If your dermatologist will not name the subtype, ask. Acne vulgaris nodulocystic is the catch-all. Conglobata, fulminans, and acne inversa (an older name for hidradenitis) are the real entries. Naming the thing helps you read the right research and skip the irrelevant advice.

The real numbers

Acne fulminans accounts for roughly 1 percent of severe acne cases, and a 2017 JAAD review found that isotretinoin-induced flares are the trigger in 39 percent of reported cases. That is why dermatologists now start isotretinoin at low doses (often 0.1 to 0.2 mg per kg per day) in young men, and pre-treat with prednisone for four weeks when they sense the risk is high.

Conglobata data is harder to pin down because chronicity blurs the registry numbers, but the most cited figure from a 2014 retrospective review in Dermatologic Therapy is that 71 percent of patients achieved sustained remission after a single course of isotretinoin dosed to a cumulative 150 mg per kg, with the remaining 29 percent needing a second course or additional anti-TNF biologics. Compared to adult acne rates, this is genuinely severe disease.

FAQ

Can fulminans recur? Yes, especially if isotretinoin is stopped too soon. Most dermatologists treat for at least six months past clearance.

Will conglobata scars resolve? The active lesions resolve. The atrophic and hypertrophic scars remain and need separate scar treatment later.

Are these the same as hidradenitis suppurativa? Not the same disease, but they cluster together. The follicular occlusion tetrad links conglobata, hidradenitis, and dissecting cellulitis of the scalp.

Can diet trigger fulminans? Diet has not been shown to trigger fulminans. The strongest trigger is isotretinoin started too high in a susceptible patient.

Sources: PubMed / JAAD (2017) review on acne fulminans diagnosis and treatment; PubMed / Dermatologic Therapy (2014) on isotretinoin in acne conglobata; AAD on severe acne treatment. See more under acne scars.